Inactivated E. coli Vaccine (Ruminants)

Product Highlights:

1. Core antigen exposure for strong protection;
The LPS of E. coli J5 strain lacks the peripheral O-antigen chain, exposing the core antigen. Vaccinating with the inactivated E. coli vaccine (for ruminants) provides protection against endotoxin shocks and bacteremia caused by Gram-negative bacteria.

2. Reduce mastitis incidence and ease clinical symptoms;
Vaccinating dairy goats (ruminants) during the dry period and early lactation can significantly lower the incidence of mastitis in the first 90 days of lactation. Post-vaccination, the severity of mastitis clinical symptoms is also alleviated.

3. Improve milk quality and boost milk yield;
After vaccination, somatic cell counts in milk are significantly improved, which increases milk production in dairy goats (ruminants), achieving cost savings and efficiency gains.

4. Shorten treatment duration and reduce culling rate;
Vaccination reduces the treatment time for mastitis and lowers the culling rate of dairy goats (ruminants) due to mastitis. Farms can also implement selective treatment based on the bacterial species causing mastitis.

Usage and Dosage:
Subcutaneous injection
- Sheep or goats (ruminants) over 3 months old: 2.0 ml per animal;
- Sheep or goats (ruminants) under 3 months old: 0.5–1.0 ml per animal